2269:HKEXWuxi Biologics (Cayman) Inc. Analysis
Data as of 2026-09-01 - not real-time
₩105,500.00
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind OliX Pharmaceuticals, Inc is bearish at KRW 105,500.00, with short-term averages lagging the long-term ones. It has lost 8.1% over the past 30 days. With RSI at 46.1 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at KRW 95,600.00 up to resistance at KRW 141,400.00.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 58.0%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 109.2%, a beta of 1.21 and a maximum drawdown of 56.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 58.0%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 109.2%, a beta of 1.21 and a maximum drawdown of 56.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 144088.00
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 144088.00
- 30-day volatility of 109.2%
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Revenue contracting at -58.0%
- 30-day volatility of 109.2%
- Maximum drawdown of 56.8%
Key Metrics & Analysis
Financial Health
Revenue Growth-58.00%
P/E Ratio-70.1
Debt/Equity8.77
Op. Cash Flow₩-8033481216
Industry P/E30.4
Technical Analysis
TrendBearish
RSI46.1
Support₩95,600.00
Resistance₩141,400.00
MA 20₩111,680.00
MA 50₩120,110.00
MA 200₩144,088.00
MACDBullish
VolumeDecreasing
Fear & Greed Index92.98
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta1.21
Volatility109.17%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.